Adjunctive Risperidone Treatment in Patients with 'clozapine-resistant Schizophrenia'
Overview
Authors
Affiliations
Treatment of the special patient with schizophrenia.
Conley R, Kelly D Dialogues Clin Neurosci. 2011; 3(2):123-35.
PMID: 22034474 PMC: 3181645.
Treatment-refractory schizophrenia.
Caspi A, Davidson M, Tamminga C Dialogues Clin Neurosci. 2011; 6(1):61-70.
PMID: 22034144 PMC: 3181784.
Benefits and risks of antipsychotic polypharmacy: an evidence-based review of the literature.
Tranulis C, Skalli L, Lalonde P, Nicole L, Stip E Drug Saf. 2007; 31(1):7-20.
PMID: 18095743 DOI: 10.2165/00002018-200831010-00002.
Risperidone augmentation of clozapine: a critical review.
Kontaxakis V, Ferentinos P, Havaki-Kontaxaki B, Paplos K, Pappa D, Christodoulou G Eur Arch Psychiatry Clin Neurosci. 2006; 256(6):350-5.
PMID: 16900439 DOI: 10.1007/s00406-006-0643-9.
Augmentation strategies in clozapine-resistant schizophrenia.
Remington G, Saha A, Chong S, Shammi C CNS Drugs. 2005; 19(10):843-72.
PMID: 16185094 DOI: 10.2165/00023210-200519100-00004.